0310-1248 : Tagrisso 40 mg Oral Tablet, Film Coated
NDC: | 0310-1248 |
Labeler: | Astrazeneca Pharmaceuticals Lp |
Product Type: | Human Prescription Drug |
Drug Name: | ![]() |
Dosage Form: | Oral Tablet, Film Coated |
Application #: | NDA208065 |
Rev. Date: |
NDC Package Codes:
- 0310-1248-30: 30 TABLET, FILM COATED IN 1 BOTTLE (0310‑1248‑30)
Active Ingredients:
- Osimertinib
Dosage Strength:
- 40 mg
Pharmaceutical Classes:
- Breast Cancer Resistance Protein Inhibitors [MoA]
- Cytochrome P450 1A2 Inducers [MoA]
- Cytochrome P450 3A Inhibitors [MoA]
- Cytochrome P450 3A4 Inducers [MoA]
- Kinase Inhibitor [EPC]
- Kinase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0310-1251 Tagrisso 80 mg Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp
- 0310-1349 Tagrisso 40 1/1 Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp
- 0310-1350 Tagrisso 80 1/1 Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0310-1222Next: 0310-1251 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.